Company
Encore Medical
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
38
510(k), De Novo and PMA
Device trials
22
As lead sponsor, any status
Adverse event reports
2,603
Received Nov 1, 2025 to Nov 20, 2026
Recall records
189
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
EMI
· Encore Medical, Inc.
Public float
Unknown
Not reported in US filings
Revenue
Not reported
Net income
Not reported
R&D spending
Not reported
Cash
Not reported
Long-term debt
Not reported
Shares outstanding
Not reported
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Apr 21, 2022 | Equity | $1.1M | $2.5M | 9 | Rule 506(b)Agent: Cedar Point Capital, LLCCommissions $275K | Form D ↗May 3, 2022 |
1 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Encore Medical, Inc.
- Headquarters
- Eagan, Minnesota
- Incorporated
- Minnesota in 2017
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1838003 ↗
Executives, directors and promoters
As listed on the latest Form D.
5 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Encore Medical.
Latest FDA decisions
The 8 newest of 38 since 2015.
K263086 · Decided Oct 2, 2026 · 30 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
37 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Encore PFO Closure Device - The PerFOrm TrialPivotal-lookingRecruiting
NCT05537753 · 500 participants (planned) · Start Jul 12, 2023 · Primary completion Apr 2026
Device: Encore PFO closure device; FDA-approved PFO closure device · For: Patent Foramen Ovale; Cryptogenic Stroke
Sites: Little Rock, Arkansas; La Jolla, California; Tampa, Florida · 8 sites in all
21 more trials with a free account
Reports received
2,603
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
26
1.0% of reports
Injury reports
2,575
99% of reports
Death reports
1
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 161 | 0 | 0 |
| Jan 24 | 2 | 165 | 0 | 0 |
| Feb 24 | 0 | 171 | 0 | 0 |
| Mar 24 | 1 | 158 | 0 | 0 |
| Apr 24 | 4 | 203 | 0 | 0 |
| May 24 | 2 | 218 | 0 | 0 |
| Jun 24 | 1 | 192 | 0 | 0 |
| Jul 24 | 3 | 158 | 0 | 0 |
| Aug 24 | 1 | 165 | 1 | 0 |
| Sep 24 | 0 | 151 | 0 | 0 |
| Oct 24 | 0 | 190 | 0 | 0 |
| Nov 24 | 0 | 123 | 0 | 0 |
| Dec 24 | 2 | 154 | 0 | 0 |
| Jan 25 | 1 | 188 | 0 | 0 |
| Feb 25 | 7 | 166 | 0 | 0 |
| Mar 25 | 3 | 140 | 0 | 0 |
| Apr 25 | 0 | 138 | 0 | 0 |
| May 25 | 3 | 182 | 0 | 0 |
| Jun 25 | 2 | 177 | 0 | 0 |
| Jul 25 | 1 | 184 | 0 | 0 |
| Aug 25 | 1 | 169 | 0 | 0 |
| Sep 25 | 1 | 150 | 0 | 0 |
| Oct 25 | 5 | 208 | 0 | 0 |
| Nov 25 | 1 | 189 | 0 | 0 |
| Dec 25 | 1 | 209 | 0 | 0 |
| Jan 26 | 0 | 155 | 0 | 0 |
| Feb 26 | 6 | 167 | 0 | 0 |
| Mar 26 | 6 | 251 | 0 | 0 |
| Apr 26 | 5 | 229 | 0 | 0 |
| May 26 | 1 | 213 | 0 | 0 |
| Jun 26 | 1 | 248 | 0 | 0 |
| Jul 26 | 0 | 180 | 0 | 0 |
| Aug 26 | 4 | 281 | 0 | 1 |
| Sep 26 | 1 | 267 | 1 | 0 |
| Oct 26 | 0 | 186 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- DJO SURGICAL2,541
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2700-2026 · Started Feb 16, 2026 · Posted by FDA Jul 8, 2026
Reason given: Due to packaging discrepancy with incorrect product size mixed up.
Cause as FDA categorized it: Process change control · Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH)
188 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.